Edward Mascioli
Chief Executive Officer at Matrivax Research & Development Corp.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Helen Hobbs | M | 71 | 13 years | |
| Daniel Geffken | M | 67 |
Matrivax Research & Development Corp.
 Matrivax Research & Development Corp. BiotechnologyHealth Technology Matrivax Research & Development Corp. is developing human vaccines for the prevention and treatment of life-threatening bacterial diseases. Its pipeline includes two vaccine candidates implementing proprietary streptococcus pneumoniae and clostridium difficile protective antigens. The company was founded in October 2007 and is headquartered in Boston, MA. | - |
| Keith Mansford | M | - |
Mindset BioPharmaceuticals Ltd.
 Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | - |
| Ansbert Gadicke | M | 66 |
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | - |
| Alfred Lewis Goldberg | M | 81 |
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | - |
| Shalom Allenstein | M | - |
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | - |
| Michael Schickler | M | 55 |
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | - |
| Christiana Goh Bardon | M | 53 |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 21 years |
| H. Robert Horvitz | M | - |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 19 years |
| Salomon Z. Langer | M | - |
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | - |
| Elizabeth Stoner | M | 73 |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 17 years |
| Barbara Tate | M | - |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 8 years |
| Houman Ashrafian | M | 49 |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 8 years |
| Denis Patrick | M | - | 14 years | |
| Laurence Barker | M | - |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Steere | M | 88 | 28 years | |
| Jeffrey Kindler | M | 68 | 8 years | |
| John W. Vander Vort | M | 59 |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | - |
| Marc Tessier-Lavigne | M | 64 | 4 years | |
| Ken Greenberg | M | - |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 3 years |
| Gary Patou | M | 65 |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 17 years |
| Robert N. Burt | M | 86 | 11 years | |
| Stuart J. M. Collinson | M | 64 |
Affinium Pharmaceuticals Ltd.
 Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | 7 years |
| Dana George Mead | M | 88 | 12 years | |
| David Stack | M | 72 |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 12 years |
| Valerie Start | M | 64 | 3 years | |
| Roger Leone | M | - | 14 years | |
| Neil Gibson | M | 67 | 4 years | |
| Trevor Anthony Mill | M | 53 | 12 years | |
| William C. Kennally | M | 68 | 5 years | |
| Dawn Halkuff | F | 53 | 6 years | |
| Randy Brenner | M | 51 | 15 years | |
| Theresa Firestone | F | - | 4 years | |
| Dieter Weinand | M | 63 | 3 years | |
| John Borgeson | M | 62 | 21 years | |
| Santiago Arroyo | M | 64 | 5 years | |
| David B. Huang | M | 49 | 3 years | |
| Ranjeev Krishana | M | 50 | 3 years | |
| Thomas Liquard | M | 51 | 4 years | |
| Dario Paggiarino | M | 67 | 10 years | |
| Shankar Musunuri | M | 60 | 14 years | |
| Alexander Fowkes | M | - | 5 years | |
| Arindam Bose | M | 71 | 6 years | |
| Jonathan Lanfear | M | 55 | - | |
| Baiyong Li | M | 56 | 12 years | |
| Aimee Crombie | M | - | 3 years | |
| Daniella Gigante | F | - | - | |
| Howard Cyr | M | - | 6 years | |
| Tanya de Foras | F | 53 | 10 years | |
| Bhooshitha B. de Silva | M | 49 | 11 years | |
| Clare Khan | M | 72 | 6 years | |
| Paulash Mohsen | M | - | 14 years | |
| Hong I. Wan | M | - | 5 years | |
| Robyn Peters | F | - | 4 years | |
| Mark Schneyer | M | 50 | 9 years | |
| Alex Goldsmith | M | - | 7 years | |
| Matthew Rossen | M | 47 | 9 years | |
| Dolca Thomas | M | 53 | 4 years | |
| Evan Loh | M | 65 | 3 years | |
| Ron Newbold | M | - | 7 years | |
| Carl Morris | M | 54 | 5 years | |
| Joseph Monahan | M | 69 | 7 years | |
| Michael Pastoor | M | - | 5 years | |
| Marc Stapley | M | 54 | 3 years | |
| Craig Fraser | M | 59 | 2 years | |
| Gregory Simon | M | 72 | 2 years | |
| Martine George | M | 76 | 5 years | |
| Michael Cooper Pearce | M | 62 | 5 years | |
| John Hubbard | M | 67 | 5 years | |
| Scott R. Shively | M | 67 | 3 years | |
| Jose-Carlos Gutiérrez-Ramos | M | 61 | 5 years | |
| Jean-Michael Halfon | M | 72 | 21 years | |
| Angela Rossetti | F | 71 | 5 years | |
| Deborah Knobelman | M | 51 | 3 years | |
| David T. Molowa | M | 64 |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 1 years |
| John Henderson | M | 79 | - | |
| John C. Kelly | M | 81 | 1 years | |
| Nat Ricciardi | M | 75 | 7 years | |
| Paul S. Miller | M | 65 | 24 years | |
| Kim Seth | M | - | 3 years | |
| Gregory S. Naeve | M | 60 | 6 years | |
| Peter H. Reinhart | M | - | 6 years | |
| Anna Berkenblit | M | 54 | 4 years | |
| Randall Kaja | M | - | 15 years | |
| Raymond Urbanski | M | 64 | 8 years | |
| David Roblin | M | 57 | 3 years | |
| Ying Song | F | - | 13 years | |
| Alan J. Wills | M | 60 | 1 years | |
| Lillian Mu | F | - | 4 years | |
| Julie LeChasseur | F | - | 4 years | |
| Anja Guntermann | M | - | 9 years | |
| Abdul Ezaz Mutlib | M | 63 | 4 years | |
| Elna van der Ryst | F | - | 11 years | |
| Brenda Mitchell | F | - | - | |
| Ilan Fogel | M | - | 7 years | |
| John Thompson | M | 57 | 7 years | |
| David Simmons | M | 59 | 16 years | |
| Barbara Wirostko | M | 58 | 4 years | |
| Shaun Stewart | M | - | 13 years | |
| Irina Apostolou | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 94 | 94.00% |
| Israel | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Edward Mascioli
- Personal Network
